Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 351

1.

Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.

Yang XH, Yamagiwa S, Ichida T, Matsuda Y, Sugahara S, Watanabe H, Sato Y, Abo T, Horwitz DA, Aoyagi Y.

J Hepatol. 2006 Aug;45(2):254-62. Epub 2006 Mar 9.

PMID:
16600416
2.

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.

Gastroenterology. 2007 Jun;132(7):2328-39. Epub 2007 Apr 14.

PMID:
17570208
3.

[Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth].

Zhang P, Zhang LN, Zhu FL, Wang Q, Wang XY, Li HY, Liu CM, Gao F, Liu CH.

Zhonghua Zhong Liu Za Zhi. 2007 May;29(5):342-5. Chinese.

PMID:
17892128
4.

[The presence and the significance of CD4+CD25+ regulatory T cells in livers of patients with hepatocellular carcinoma].

Yang XH, Liu BR, Jiang HC.

Zhonghua Gan Zang Bing Za Zhi. 2007 Apr;15(4):279-82. Chinese.

PMID:
17456316
5.

Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.

Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ.

Hepatology. 2005 Apr;41(4):722-30.

PMID:
15791620
6.

Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells.

Cao M, Cabrera R, Xu Y, Firpi R, Zhu H, Liu C, Nelson DR.

Lab Invest. 2007 Jun;87(6):582-90. Epub 2007 Mar 19.

7.

Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.

Yang ZQ, Yang ZY, Zhang LD, Ping-Bie, Wang SG, Ma KS, Li XW, Dong JH.

Hum Immunol. 2010 Dec;71(12):1180-6. doi: 10.1016/j.humimm.2010.09.011. Epub 2010 Sep 24.

PMID:
20870003
8.

Characterization of CD4+ FOXP3+ T-cell clones established from chronic inflammatory lesions.

Okui T, Ito H, Honda T, Amanuma R, Yoshie H, Yamazaki K.

Oral Microbiol Immunol. 2008 Feb;23(1):49-54. doi: 10.1111/j.1399-302X.2007.00390.x.

PMID:
18173798
9.

A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.

Xu G, Mou Z, Jiang H, Cheng L, Shi J, Xu R, Oh Y, Li H.

Laryngoscope. 2007 May;117(5):876-80.

PMID:
17473687
10.

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Krüger C, Manns MP, Greten TF, Korangy F.

Gastroenterology. 2008 Jul;135(1):234-43. doi: 10.1053/j.gastro.2008.03.020. Epub 2008 Mar 21. Erratum in: Gastroenterology. 2011 Aug;141(2):779.

PMID:
18485901
11.

Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.

Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA.

Inflamm Bowel Dis. 2007 Feb;13(2):191-9.

PMID:
17206665
12.

Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.

Zhu J, Feng A, Sun J, Jiang Z, Zhang G, Wang K, Hu S, Qu X.

J Gastroenterol Hepatol. 2011 Oct;26(10):1519-26. doi: 10.1111/j.1440-1746.2011.06765.x.

PMID:
21557772
14.

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.

PMID:
19022917
15.

Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.

Yang G, Liu A, Xie Q, Guo TB, Wan B, Zhou B, Zhang JZ.

Int Immunol. 2007 Feb;19(2):133-40. Epub 2006 Dec 20.

PMID:
17182968
16.

Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.

Shen X, Li N, Li H, Zhang T, Wang F, Li Q.

J Cancer Res Clin Oncol. 2010 Nov;136(11):1745-54. doi: 10.1007/s00432-010-0833-8. Epub 2010 Mar 10.

PMID:
20221638
17.

[The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].

Zhang HH, Fei R, Mei MH, Liao WJ, Wang XY, Cong X, Qin LL, Ji Y, Wang SX, Wei L, Chen HS.

Zhonghua Gan Zang Bing Za Zhi. 2007 Apr;15(4):266-72. Chinese.

PMID:
17456313
18.

CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.

Shen LS, Wang J, Shen DF, Yuan XL, Dong P, Li MX, Xue J, Zhang FM, Ge HL, Xu D.

Clin Immunol. 2009 Apr;131(1):109-18. doi: 10.1016/j.clim.2008.11.010. Epub 2009 Jan 18.

PMID:
19153062
19.

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.

Exp Hematol. 2007 Mar;35(3):416-25.

PMID:
17309822
20.

Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.

Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG.

Arthritis Rheum. 2007 Jun;56(6):2080-91.

Supplemental Content

Support Center